Lurker Nancy 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jul 11, 2025
Insider Transaction Report
Form 4
Lurker Nancy
Director
Transactions
- Exercise/Conversion
Common Stock
2025-07-10+11,111→ 216,547 total - Exercise/Conversion
Restricted Stock Units
2025-07-10−11,111→ 11,112 totalExercise: $0.00→ Common Stock (11,111 underlying)
Holdings
- 126,889(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F2]The restricted stock units vests in three ratable annual installments beginning July 10, 2024.